Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.
During Tuesday’s CNN tea party presidential nominee debate two of the candidates sparred over perhaps an unlikely issue: the HPV vaccine. Republican Congresswoman Michele Bachmann criticized Republican Governor Rick Perry for signing an executive order in 2007 requiring middle school age girls in the state of Texas to have the vaccine – an order that was subsequently blocked by the Texas state legislature. Her comments renewed debate over the risks and benefits of the HPV vaccine …and what role, if any, the government should have with regard to who gets vaccinated. Diane and her guests discuss benefits and risks of the HPV vaccine.
- Liz Szabo reporter, USA Today
- Dr. Renata Sanders adolescent Health general pediatrics and adolescent medicine, Johns Hopkins Children's Center
- Dr. Roberta DeBiasi pediatric infectious diseases physician at Children’s National Medical Center
- Peter Sprigg vice president for policy at the Family Research Council
Most Recent Shows
Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.
Russian President Putin is widely popular in Russia, despite his ruthless reputation abroad. A former Moscow bureau chief for The New York Times explains how Putin rose from obscurity to become one of the world’s most powerful and enigmatic leaders.
The owner of a drug company has come under fire for dramatically raising the price of medicine that fights deadly infections. And the prices of some heart medications have also spiked. We look at the renewed controversy over high drug prices in the U.S.